Taiwan Liposome Company Ltd Net Income per Employee (TLC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Taiwan Liposome Company Ltd   (NASDAQ: TLC)
 

Taiwan Liposome Ltd Net Income per Employee

TLC's Quarterly Results, Trends, Rankings, Statistics
Taiwan Liposome Company Ltd recorded a cumulative net loss of $-35 million during 12 month ending in the fourth quarter 2020.
The Healthcare sector has seen employees of 114 other companies achieving higher income per employee. While Taiwan Liposome Ltd 's total ranking has deteriorated compared to the previous quarter from 0 to 3306.


What is Income per Employee Ratio?






TLC Net Income per Employee (Dec 31 2020)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -175,090 -134,995 -134,995 -134,995 -134,995
TLC's Total Ranking # 3306 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


TLC Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 115
Healthcare Sector # 348
Overall Market # 3306

Net Income per Employee Statistics
High Average Low
$ -134,995 $ -152,452 $ -175,090
(Dec 31 2019)   (Dec 31 2020)







Companies with similar Income per Employee for 12 month ending Dec 31 2020, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2020Number of Employees Dec 31 2020


Date modified: 2026-06-22T16:58:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.